Skip to main content
Veterinary Medicines

Nobivac SHP

Authorised
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine distemper virus, strain Onderstepoort, Live

Product identification

Medicine name:
Nobivac SHP
Active substance:
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine distemper virus, strain Onderstepoort, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    251189000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    3162280.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine distemper virus, strain Onderstepoort, Live
    1000000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD02
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 204a/97
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 30/03/2022

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 16/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."